Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adila Izgutdina

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|March 1, 2023
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenograftsRex H Lee, Ritu Roy, Hua Li, et al.
Biochemical and Biophysical Research Communications|March 28, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancerShorook Naara, Zhibin Cui, Adila Izgutdina, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid LeukemiaAmrik S Kang, Haley Johnson, Nicole Lei, et al.
Journal for Immunotherapy of Cancer|November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignanciesWilliam C Temple, Matthew A Nix, Akul Naik, et al.
Nature Communications|April 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemiaJuwita Werner, Alex G Lee, Chujing Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Nature Cancer|October 31, 2023
Structural surfaceomics reveals an AML-specific conformation of integrin β<sub>2</sub> as a CAR T cellular therapy targetKamal Mandal, Gianina Wicaksono, Clinton Yu, et al.
Blood|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|March 1, 2023
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenograftsRex H Lee, Ritu Roy, Hua Li, et al.
Biochemical and Biophysical Research Communications|March 28, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancerShorook Naara, Zhibin Cui, Adila Izgutdina, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid LeukemiaAmrik S Kang, Haley Johnson, Nicole Lei, et al.
Journal for Immunotherapy of Cancer|November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignanciesWilliam C Temple, Matthew A Nix, Akul Naik, et al.
Nature Communications|April 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemiaJuwita Werner, Alex G Lee, Chujing Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Nature Cancer|October 31, 2023
Structural surfaceomics reveals an AML-specific conformation of integrin β<sub>2</sub> as a CAR T cellular therapy targetKamal Mandal, Gianina Wicaksono, Clinton Yu, et al.
Blood|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cellsCorynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Pageof 1